My male pattern baldness journey from age 18 to 29
    Shaved/buzzed 3/9/2024

    A user shared their experience with male pattern baldness and accepting baldness after shaving their head at age 29. Some responses suggest treatments like minoxidil and finasteride, while others discuss acceptance and personal experiences with hair loss.
    View this post in the Community →

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Minoxidil: A Comprehensive Review

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.
      Overactive Bladder in Men: Finasteride for Androgenetic Alopecia

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      Finasteride increases hair count and improves hair growth with low risk of side effects.
      Androgenetic Alopecia: Case Study and Treatment Options

      research Androgenetic Alopecia

      November 2015 in “Springer eBooks”
      Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research (2015)

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.